^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GraftAssureDx™

    Company:
    Oncocyte
    Related tests:
    Details
    Evidence

    News

    1m
    Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission (Oncocyte Press Release)
    "Insight Molecular Diagnostics Inc...today announced that in February the company completed several major milestones to support the GraftAssureDx™ test kit clinical trial for its planned in vitro diagnostic (IVD) De Novo submission to the U.S. Food and Drug Administration (FDA) and also received its ISO 13485 certification."
    Clinical
    |
    GraftAssureDx™